News

Women less likely to receive treatment for deadly heart condition

Women less likely to receive treatment for deadly heart condition

Forest plot showing adjusted hazard ratios for referral to secondary cardiology/cardiac surgery services and aortic valve intervention where the reference group for ethnic groups is the white group, males for females and Index of multiple deprivation (IMD) is level 1 (most affluent group). Credit: British Heart Foundation Women, people from ethnic minority backgrounds, and those

Increasing numbers of US adults don’t know they have diabetes, high blood pressure or high cholesterol

Increasing numbers of US adults don’t know they have diabetes, high blood pressure or high cholesterol

Credit: Antoni Shkraba Studio from Pexels In a new report published in JAMA Cardiology, health policy experts at the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) have shown that many US adults are unaware they have high blood pressure, diabetes and high cholesterol—three major risk

P2Y12 drugs may be better than aspirin to prevent heart attack and stroke in patients with coronary artery disease

P2Y12 drugs may be better than aspirin to prevent heart attack and stroke in patients with coronary artery disease

Credit: Pixabay/CC0 Public Domain Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of cardiovascular death, heart attack and stroke compared with traditional aspirin, with no increased risk of major bleeding, finds a study published by The BMJ. P2Y12 inhibitors are often given to patients alongside aspirin

Breast Implants Linked to Unexpected Cardiac Risks in Women

Silicone breast implants were introduced in the 1960s and have since gained popularity as staples in plastic surgery for aesthetic and reconstructive purposes. Health concerns related to breast implants have sparked intense debate due to inconclusive evidence regarding long-term outcomes. A significant challenge lies in the absence of reliable population-based estimates of implant prevalence rates

Panel recommends statins for adults with HIV at risk for cardiovascular disease

Panel recommends statins for adults with HIV at risk for cardiovascular disease

Credit: Pixabay/CC0 Public Domain In February 2024, the U.S. Department of Health and Human Services Panel for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (ARV Guidelines Panel), in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), and the HIV Medicine Association (HIVMA), developed statin therapy recommendations

Study provides a window into public perceptions about technological treatment options for brain conditions

Study provides a window into public perceptions about technological treatment options for brain conditions

Graphical abstract. Credit: Device (2025). DOI: 10.1016/j.device.2025.100804 Given the rise in brain-based conditions and the growing development and investment in neurotechnologies to target them, it is important to understand how the public views these interventions and whether they would be willing to use them. To explore this, researchers conducted a survey of over 1,000 U.S.